breaking news

Court of appeals blocks Austin’s paid sick leave ordinance

HHS Secretary Azar avoids being drawn into fight over preexisting conditions

The HHS secretary contends drug manufacturers face hurdles in trying to lower prescription prices.


Health and Human Services Secretary Alex Azar told lawmakers Tuesday that he wants to preserve access to affordable insurance for Americans with preexisting medical conditions, but he declined to disclose his view of an administration move that could undercut such consumer protections. 

Calling it "a constitutional position . . . not a policy position," Azar sidestepped grilling on whether he agreed with a legal brief filed last week by Justice Department attorneys stating they would not defend the Affordable Care Act in a federal lawsuit by Texas and 19 other Republican-led states. 

During a hearing before the Senate Health, Education, Labor and Pensions Committee that was mainly about the president's blueprint to address drug prices, Sen. Maggie Hassan, D-N.H., told Azar that Justice's legal position is "like some kind of a sick joke." The administration argues that the ACA's individual mandate, requiring most people to carry health insurance, will become unconstitutional next year — and, with it, the law's insurance protections for consumers. 

"Will you encourage the Trump administration to change its position?" Hassan challenged Azar, a lawyer and former HHS general counsel. 

He replied that "we do believe in finding solutions on the matter of preexisting conditions and the matter of affordability, regardless of the litigation." 

The committee's Republicans were silent on the question, even though some GOP lawmakers have said they were bewildered by the Justice Department's surprise stance. The move has become a lightning rod ahead of the November midterm elections. 

Democrats also pressed Azar on a statement by President Donald Trump last month that drug companies would, within two weeks, "announce voluntary, massive drops in prices." 

"That would be tomorrow," noted Sen. Elizabeth Warren, D-Mass., challenging Azar to name companies that have carried out Trump's promise. 

The secretary said several drug manufacturers have told federal officials that "they want to execute substantial price reductions" but are "encountering hurdles." Pharmacy benefit managers (PBMs), he said, are threatening to drop those companies' drugs from formularies — that is, lists of medicines covered by an insurer — because lower list prices would translate into smaller profits for the PBMs. "I find that unconscionable," he said. 

Azar's remarks were consistent with the administration's portrayal of "middle men," not the pharmaceutical industry itself, as the root of the nation's high drug prices. He reiterated that direct government negotiation of drug prices in the vast Medicare program — a longtime Democratic goal that Trump embraced during his campaign — would be ineffective. 

Azar noted that the Food and Drug Administration on Tuesday issued final guidelines designed to make it easier for pharmaceutical companies and insurers to negotiate prices based on a drug's value and effectiveness. 

The rules, first drafted during the final days of the Obama administration, define permissible "medical communications" between the manufacturers and payers such as health plans and hospitals. They fit within a priority of Azar's to shift health-care payments from methods based on the amount of treatment provided to ones based on services' quality and effectiveness. 

FDA Commissioner Scott Gottlieb said the guidance clarifies how drug companies may communicate information about patient outcomes that are important to purchasers, but are not expressly included in a product's approved labeling. 

For example, Gottlieb said in an interview, drug companies might have information on how a particular drug helps to reduce the length of hospital stays or whether patients need to be readmitted to a hospital. While such data are not part of the approved labels, they "may be of interest to health plans and easy to measure." 

His agency wants to encourage competitive contracting based on such measures and "not get in the way" of such negotiations, he added. 

Drug companies develop information on the economic value of their medications. But they have indicated to the FDA that they feel inhibited in sharing certain economic data with payers because of legal concerns. 

A spokesman for the Pharmaceutical Research and Manufacturers of America, the main trade group for the drug industry, praised the new guidelines. They address "one barrier that has restricted how much information biopharmaceutical companies can share with insurance companies about the potential value of a medicine," the spokesman said.


Reader Comments ...


Next Up in Politics

Lawyers accuse Alex Jones of deleting evidence in Sandy Hook case
Lawyers accuse Alex Jones of deleting evidence in Sandy Hook case

Lawyers for the families of two Sandy Hook shooting victims are accusing conspiracy theorist Alex Jones and his Infowars media business of intentionally destroying evidence relevant to defamation cases against him, according to a motion filed on Friday in an Austin court. Jones is being sued in Travis County by the families of nine Sandy Hook victims...
U.S. productivity grew at strong 2.9% rate in Q2
U.S. productivity grew at strong 2.9% rate in Q2

U.S. productivity grew at an annual rate of 2.9 percent in the second quarter, the fastest pace in more than three years, while labor costs actually fell. The April-June increase in productivity followed a much weaker 0.3 percent rate of gain in the first quarter, the Labor Department reported. It was the strongest advance since a 3.1 percent gain...
Travis County state judges recommend renewing Southwest Key contracts
Travis County state judges recommend renewing Southwest Key contracts

As political activists push Travis County to end its relationship with Southwest Key, the federal contractor operating detention centers across the U.S. for immigrant children, the county’s juvenile probation board on Thursday recommended renewing county contracts with the Austin nonprofit. The board — made up of state District Court judges...
McRaven to Trump: Revoke my security clearance as well
McRaven to Trump: Revoke my security clearance as well

Bill McRaven, former chancellor of the University of Texas System and a retired four-star admiral and Navy SEAL, is asking President Donald Trump to revoke his security clearance. In an open letter to Trump published online Thursday in the Washington Post, McRaven said former CIA Director John Brennan, whose security clearance the president revoked...
Austin City Council votes ‘yes’ to MLS at McKalla Place
Austin City Council votes ‘yes’ to MLS at McKalla Place

Major League Soccer in Austin is closer than ever to becoming a reality after the City Council voted Wednesday to strike a deal with an ownership group that will build a stadium near the Domain. Ten months after Anthony Precourt announced his intent to move to Austin, the council voted 7-4 to allow the investor/operator of Columbus Crew SC...
More Stories